Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Tax Withholding | 2024-03-04 5:29 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 18,091 | $4.13 | 357,983 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:29 pm | N/A 2034-02-28 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 192,443 | $0 | 357,983 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-02 6:28 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 4,323 | $5.35 | 302,914 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 6:28 pm | N/A 2033-02-28 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 218,055 | $0 | 302,914 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-01 7:28 pm | N/A 2032-02-29 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 122,568 | $0 | 156,799 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-22 4:53 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 3,100 | $1.933 | 38,047 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-22 4:53 pm | N/A 2026-02-28 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 5,716 | $0 | 38,047 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-22 4:53 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 2,616 | $1.173 | 38,047 (Direct) | View |
| 2021-11-01 Option Award | 2021-11-02 7:31 pm | N/A 2031-10-31 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 65,000 | $0 | 93,515 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 4:54 pm | N/A 2031-02-03 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Senior Vice President, Finance | 82,000 | $0 | 82,000 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-19 5:00 pm | N/A 2025-06-18 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Senior Vice President, Finance | 4,728 | $0 | 26,813 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-19 5:00 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Senior Vice President, Finance | 4,728 | $0.3 | 26,813 (Direct) | View |
| 2020-07-09 Option Award | 2020-07-13 7:00 pm | N/A 2030-07-08 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Senior Vice President, Finance | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2020-07-09 6:00 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Senior Vice President, Finance | 0 | $0 | 116,838 (Direct) | View |